U.S. RESEARCH ROUNDUP-Nextera Energy, Nextpower, TKO Group

Reuters
Yesterday
U.S. RESEARCH ROUNDUP-Nextera Energy, Nextpower, TKO Group

Dec 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nextera Energy, Nextpower and TKO Group on Wednesday.

HIGHLIGHTS

* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $169 from $154

* $Nextera Energy Inc(NEE-N)$ NEE.N: Jefferies raises target price to $88 from $85

* Nextpower Inc NXT.O: Jefferies raises target price to $107 from $102

* Prologis Inc PLD.N: BTIG raises target price to $155 from $134

* TKO Group TKO.N: BTIG raises target price to $250 from $235

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $169 from $154

* Capsovision Inc CV.O: Benchmark raises target price to $14 from $5

* Community West Bancshares CWBC.O: KBW raises target price to $25 from $23

* Digitalbridge Group Inc DBRG.N: Truist Securities cuts to hold from buy

* Ekso Bionics Holdings Inc EKSO.O: H.C. Wainwright cuts to neutral rating

* Freeport-Mcmoran Inc FCX.N: Raymond James raises target price to $53 from $49

* Globalfoundries Inc GFS.O: Wedbush cuts target price to $40 from $42

* Globalfoundries Inc GFS.O: Wedbush cuts to neutral from outperform

* Marriott MAR.O: Argus Research raises target price to $370 from $310

* Nextera Energy Inc NEE.N: Jefferies raises target price to $88 from $85

* Nextpower Inc NXT.O: Jefferies raises target price to $107 from $102

* Prologis Inc PLD.N: BTIG raises target price to $155 from $134

* TKO Group TKO.N: BTIG raises target price to $250 from $235

* Vanda Pharmaceuticals Inc VNDA.O: B. Riley raises target price to $14 from $11

* Vanda Pharmaceuticals Inc VNDA.O: Jefferies raises target price to $7.5 from $5

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10